Transplanting stem cells derived from umbilical cord blood cells and menstrual blood cells may offer future therapeutic benefit for those suffering from stroke, Alzheimer's disease, and amyotrophic lateral sclerosis (ALS), ...
Mar 07, 2011
not rated yet
0
Researchers at the University of California, Santa Cruz, have identified a key molecule for establishing blood stem cells in their niche within the bone marrow. The findings, reported in the January issue of Cell Stem Ce ...
Jan 06, 2011
5 / 5 (1)
0
| 
A very unusual blood transplant appears to have cured an American man living in Berlin of infection with the AIDS virus, but doctors say the approach is not practical for wide use. The man, who is in his 40s, had a blood ...
Dec 15, 2010
5 / 5 (16)
16
A decade of refinements in marrow and stem cell transplantation to treat blood cancers significantly reduced the risk of treatment-related complications and death, according to an institutional self-analysis of transplant-patient ...
Nov 24, 2010
not rated yet
2
The National Institutes of Health has awarded a three-year, $3.9 million grant to Children's Hospital Boston researchers and their colleagues to develop a therapy to treat Fanconi anemia, a fatal genetic blood disease.
Oct 22, 2010
5 / 5 (1)
0
Researchers have determined the structure of a protein that helps guide blood-forming stem cells, or hematopoetic stem cells. The protein is also one of the main receptors used by the human immunodeficiency ...
Oct 07, 2010
5 / 5 (2)
0
|
One of the major challenges in stem cell transplants is how to obtain sufficient numbers of these remarkably rare cells to put into patients. To help overcome this issue, research from the Centenary Institute, ...
Oct 03, 2010
5 / 5 (4)
0
|
In a rare success for the much-headlined vision of gene therapy, scientists said on Wednesday they had corrected flawed DNA in an 18-year-old man suffering from a debilitating form of anaemia.
Sep 15, 2010
4.3 / 5 (3)
1
bluebird bio (formerly Genetix Pharmaceuticals Inc.) today announced publication in the journal Nature of its promising Phase 1/2 data highlighting positive results of LentiGlobin gene therapy treatment in a young adult ...
Sep 15, 2010
5 / 5 (1)
0
Allogeneic (donor-derived) stem cell transplant (alloSCT) may be a promising option for patients with treatment-resistant chronic lymphocytic leukemia (CLL), regardless of the patient's underlying genetic abnormalities, according ...
Jul 02, 2010
not rated yet
0
(PhysOrg.com) -- The Human Immunodeficiency Virus (HIV) is widely treated using highly active antiretroviral therapy (HAART), which patients must continue throughout their lives. Now a new study suggests the patients’ own ...
Jun 18, 2010
5 / 5 (2)
0
|
(PhysOrg.com) -- Researchers at the Queensland Institute of Medical Research (QIMR) and the Royal Brisbane Women's Hospital have identified a previously undiagnosed condition and successfully treated it by performing an experimental ...
May 17, 2010
5 / 5 (6)
0
An examination of the world-wide use of hematopoietic stem cell transplantation (HSCT), which involves transplantation of blood stem cells derived from the bone marrow or blood, finds that there are significant differences ...
Apr 27, 2010
not rated yet
0
Scientists at Duke University Medical Center have identified a new growth factor that stimulates the expansion and regeneration of hematopoietic (blood-forming) stem cells in culture and in laboratory animals. The discovery, ...
Mar 21, 2010
5 / 5 (3)
0
|
Scientists at Fred Hutchinson Cancer Research Center have cleared a major technical hurdle to making umbilical-cord-blood transplants a more widely-used method for treating leukemia and other blood cancers.
Jan 17, 2010
5 / 5 (3)
0
|
